Experienced in Hypophosphatasia (HPP)

Peter J. Selby

100 Stokes St, 
Toronto, ON, CA 
Experienced in Hypophosphatasia (HPP)
100 Stokes St, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Peter Selby practices in Toronto, Canada. Mr. Selby is rated as an Experienced expert by MediFind in the treatment of Hypophosphatasia (HPP). His top areas of expertise are Renal Cell Carcinoma (RCC), Severe Acute Respiratory Syndrome (SARS), Prostate Cancer, Melanoma, and Kidney Transplant.

His clinical research consists of co-authoring 371 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypophosphatasia (HPP).

Gender
Male

Locations

100 Stokes St, Toronto, ON, Canada
Other Locations
500 University Ave, Toronto, Canada
1 King's College Circle, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
Enrollment Status: Completed
Publish Date: September 17, 2025
Intervention Type: Drug
Study Drugs: Teriparatide, Zoledronic Acid
Study Phase: Phase 4
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
View 1 Less Clinical Trial

371 Total Publications

Behaviour change techniques reported in intervention studies of alcohol and tobacco use: a rapid review.
Behaviour change techniques reported in intervention studies of alcohol and tobacco use: a rapid review.
Journal: Health psychology and behavioral medicine
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Selby's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile